Skip to main content
. Author manuscript; available in PMC: 2017 Aug 1.
Published in final edited form as: Crit Care Med. 2016 Aug;44(8):e651–e663. doi: 10.1097/CCM.0000000000001637

Figure 3.

Figure 3

SRT1720 decreases inflammation after hepatic ischemia-reperfusion (I/R). Ischemic liver tissue and blood of the vehicle- and SRT1720- treated mice were collected 24 hr after reperfusion. Messenger RNA expression of (A) interleukin-6 (IL-6) and (B) interleukin-1β (IL-1β) as measured by RT-PCR. IL-6 protein levels were measured in the (C) liver tissue lysates and (D) serum by enzyme-linked immunosorbent assay. Data are presented as means ± SE (n = 6-8/group). *P < 0.05 versus control; #P < 0.05 versus vehicle.